☰
  • Home
  • Blog
  • Policy Papers
  • Analysis
  • Report Cards
  • Summits
  • You’re Invited
Logo
  • Blog
  • Policy Papers
  • Report Cards
  • Analysis
  • Summits

Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies

December 10, 2020

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community.

Read the Letter

Tags: Cardiovascular, Cost Value

Categorized in: Analysis

Recent Blog Posts

Why Don’t Insurers Take Obesity Seriously?  June 30, 2022
Feds Poised to Take a Hard Look at Pharmacy Benefit Managers June 28, 2022
Federal Court Upholds West Virginia Law that Reigns in “Bad Drug” Ads June 24, 2022

2020 K Street NW, Suite 505 Washington, DC 20006 (202) 964-2624

About Us Archive

© 2022 Copyright Institute for Patient Access